Lotus Eye Hospital & Institute
Lotus Eye Hospital & Institute Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Lotus Eye Hospital & Institute Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Lotus Eye Hospital & Institute Ltd trades at a P/E of 3407.00× and P/B of 4.34×.
Valuation
Profitability
Growth
Financial Health
Lotus Eye Hospital & Institute Ltd financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Lotus Eye Hospital & Institute Ltd, switchable between annual and quarterly views, consolidated or standalone.
Lotus Eye Hospital & Institute Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹275.18 Cr and reported EPS of ₹0.04.
Lotus Eye Hospital & Institute segment analysis: revenue and profit mix.
Disclosed business segments at Lotus Eye Hospital & Institute with their share of revenue and profit, switchable between consolidated and standalone reporting.
Lotus Eye Hospital & Institute discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
Lotus Eye Hospital & Institute Ltd investment thesis: bull case, bear case, and the flip lines.
Why someone would buy Lotus Eye Hospital & Institute Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
What you're getting.
No strengths or opportunities on record.
What can break it.
No weaknesses or threats on record.
What would change my mind.
Trim if P/E re-rates above 4429. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 26.83. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Lotus Eye Hospital & Institute Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Lotus Eye Hospital & Institute Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
Lotus Eye Hospital & Institute Ltd technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Lotus Eye Hospital & Institute Ltd — derived from the live tape, not yesterday's close.
Lotus Eye Hospital & Institute Ltd last traded at ₹132.86 with an intraday range of ₹131–₹139.35 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹132.86| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 154.51 | +21.65 | +16.29% |
| R3 | 146.16 | +13.30 | +10.01% |
| R2 | 142.75 | +9.89 | +7.45% |
| R1 | 137.81 | +4.95 | +3.72% |
| PIVOT | 134.40 | 1.54 | 1.16% |
| CURRENT | 132.86 | — | — |
| S1 | 112.76 | -20.10 | -15.13% |
| S2 | 121.11 | -11.75 | -8.85% |
| S3 | 126.05 | -6.81 | -5.12% |
| S4 | 129.46 | -3.40 | -2.56% |
LOTUSEYE is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 134.14 ~ 139.35
Trading Inside opening range
Lotus Eye Hospital & Institute Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Lotus Eye Hospital & Institute Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Lotus Eye Hospital & Institute Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Lotus Eye Hospital & Institute Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Lotus Eye Hospital & Institute Ltd stood at 31.8% of traded volume, against a 20-day average of 58.4%.
Lotus Eye Hospital & Institute announcements: results, concalls, ratings, M&A.
Filings Lotus Eye Hospital & Institute sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Lotus Eye Hospital & Institute files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 43 documents below.
Updates
LOTUSEYE: Lotus Eye Hospital and Institute Limited has informed the Exchange regarding the financial results for the period ended March 31, 2026 in…
Copy of Newspaper Publication
LOTUSEYE: Lotus Eye Hospital and Institute Limited has informed the Exchange about Copy of Newspaper Publication regarding the Standalone Audited…
Updates
LOTUSEYE: Lotus Eye Hospital and Institute Limited has informed the Exchange regarding 'Non-applicability of SEBI Circular on Large Corporates
Certificate under SEBI (Depositories and Participants) Regulations, 2018
LOTUSEYE: Lotus Eye Hospital and Institute Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and…
Trading Window
Lotus Eye Hospital and Institute Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider…
Lotus Eye Hospital & Institute dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Lotus Eye Hospital & Institute has declared, sequenced by announce and record date.
Lotus Eye Hospital & Institute corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Lotus Eye Hospital & Institute Ltd: business, sector, key facts.
What Lotus Eye Hospital & Institute Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Lotus Eye Hospital & Institute Ltd operates in the Healthcare, listed as NSE: LOTUSEYE, BSE: 532998.
Lotus Eye Hospital and Institute Limited is a prominent specialty eye care hospital in India, established in 1989 and headquartered in Coimbatore. The hospital offers a comprehensive range of ophthalmic services, catering to diverse patient needs and encompassing various subspecialties.
Their surgical services are extensive, including a wide array of refractive procedures such as ReLEx SMILE lasik, LASIK eye surgery, epilasik, and Intralase, alongside advanced cataract surgery techniques like robotic femto laser cataract surgery, phacoemulsification, micro incision cataract surgery (MICS), and small incision cataract surgery (SICS). They also perform a variety of corneal surgeries, including penetrating keratoplasty (PKP), deep anterior lamellar keratoplasty (DALK), and corneal patch grafts, as well as glaucoma surgeries like trabeculectomy and other procedures addressing conditions like pterygium and retinal detachments. The hospital also provides specialized pediatric eye care and squint surgery.
Beyond surgical interventions, Lotus Eye Hospital offers a full spectrum of medical treatments. This includes injections for various retinal diseases (like Avastin, Lucentis, and Eylea), management of conditions such as keratoconus, glaucoma, diabetic retinopathy, uveitis, and neuro-ophthalmological disorders. They also address common issues like computer vision syndrome and binocular vision problems.
The hospital's commitment extends beyond direct patient care. It operates an in-house eye bank, optical showroom, and pharmacy, providing patients with convenient access to essential resources. Furthermore, its commitment to education and research is evident through its operation of a research trust, offering a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program, contributing to the advancement of ophthalmic care in India.
In summary, Lotus Eye Hospital and Institute Limited provides a holistic approach to eye care, integrating advanced surgical techniques, comprehensive medical treatments, supportive ancillary services, and educational initiatives to establish itself as a leading provider of ophthalmic services in India.
Questions investors ask about Lotus Eye Hospital & Institute Ltd (LOTUSEYE).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Lotus Eye Hospital & Institute Ltd (LOTUSEYE)?
The current share price of Lotus Eye Hospital & Institute Ltd (LOTUSEYE) is ₹132.86. Today, the stock has declined by ₹3.42 (2.51%), trading in a range of ₹131 to ₹139.35. The stock opened at ₹138.3 with a trading volume of 27,878 shares.
02Is Lotus Eye Hospital & Institute Ltd stock a good investment for long-term?
Lotus Eye Hospital & Institute Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹275.18 crores, P/E ratio of 3407.00, ROE of 0.13%, and ROCE of 2.79%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Lotus Eye Hospital & Institute Ltd stock?
The 52-week high price of Lotus Eye Hospital & Institute Ltd (LOTUSEYE) is ₹147, while the 52-week low is ₹67.72. Currently trading at ₹132.86, the stock is 82.2% away from its 52-week low and 9.6% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Lotus Eye Hospital & Institute Ltd stock at the current price?
Whether to buy Lotus Eye Hospital & Institute Ltd stock at ₹132.86 depends on multiple factors. The stock is currently trading with a P/E ratio of 3407.00 and P/B ratio of 4.34. Today's performance shows a loss of 2.51%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Lotus Eye Hospital & Institute Ltd and when is the next dividend?
Lotus Eye Hospital & Institute Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹132.86, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Lotus Eye Hospital & Institute Ltd?
Lotus Eye Hospital & Institute Ltd's key financial metrics include: P/E Ratio: 3407.00, P/B Ratio: 4.34, ROE: 0.13%, ROCE: 2.79%, Dividend Yield: 0.00%, EPS: ₹0.04, Book Value: ₹31.41, and Debt-to-Equity: 26.33. The company's market cap stands at ₹275.18 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Lotus Eye Hospital & Institute Ltd stock performing today in the market?
Lotus Eye Hospital & Institute Ltd stock opened at ₹138.3 and is currently trading at ₹132.86, showing a decline of ₹3.42 (2.51%). The intraday high is ₹139.35 and low is ₹131. The trading volume stands at 27,878 shares, indicating moderate market participation today.
08What is the P/E ratio of Lotus Eye Hospital & Institute Ltd and what does it indicate?
Lotus Eye Hospital & Institute Ltd has a Price-to-Earnings (P/E) ratio of 3407.00, which means investors are willing to pay ₹3407.00 for every ₹1 of earnings. With an EPS of ₹0.04, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Lotus Eye Hospital & Institute Ltd (LOTUSEYE) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwals Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Artemis Medicare Services (ARTEMISMED) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy